AIM
CALA

Axiom Investment Management’s Calithera Biosciences, Inc CALA Stock Holding History

Axiom Investment Management’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-250
Closed – – 475
2022
Q3 		$0 Buy
+250
New +$855 ﹤0.01% 477
2021
Q2 		– Sell
-150
Closed -$7K – 211
2021
Q1 		$7K Buy
+150
New +$8.73K 0.01% 185

Other funds holding CALA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCMG
TSP Capital Management Group Summit, New Jersey $418M AUM 68.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Axiom Investment Management's CALA Position: Q4 2022 in Review

Axiom Investment Management sold out of Calithera Biosciences, Inc (CALA) in Q4 2022, closing a stake of 250 shares.

Axiom Investment Management first reported a position in CALA in Q1 2021 and held it in 2 quarters. The position peaked at $7K in Q1 2021. 23 funds tracked by Wall St. Rank hold CALA as of Q4 2022.

  • Axiom Investment Management reported no remaining Calithera Biosciences, Inc position as of Q4 2022 after selling out during the quarter.
  • Axiom Investment Management sold 250 Calithera Biosciences, Inc shares in Q4 2022.
  • Axiom Investment Management first reported a position in Calithera Biosciences, Inc in Q1 2021 and held it in 2 quarters.
  • Axiom Investment Management's Calithera Biosciences, Inc position peaked at $7K in Q1 2021.
  • 23 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q4 2022.

Based on Axiom Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.